Real-time enrollment status for this hypertrophic cardiomyopathy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:56 AM UTC
| NCT Number | NCT06481891 |
| Recruiting Status | Recruiting |
| Condition | Hypertrophic Cardiomyopathy |
| Phase | PHASE3 |
| Target Enrollment | 500 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Lexicon Pharmaceuticals |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 17, 2026: Clinical trial NCT06481891 is currently recruiting participants. This phase3 study for hypertrophic cardiomyopathy is actively seeking new participants at 33 locations across the United States. The study is sponsored by Lexicon Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06481891 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06481891 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.